-
Bipartisan Right To Try Act Would Compel DEA To Allow Psychedelics And Cannabis For Certain Patients
Friday, March 31, 2023 - 4:47pm | 471Congressional Reps. Earl Blumenauer (D-OR) and Nancy Mace (R-SC) filed a bill to allow terminally-ill patients to access Schedule I drugs that have been tested in clinical trials, such as cannabis and certain psychedelics under the federal Right to Try (RTT) laws. The new HR1825 aims...
-
Congress: Two New Bills Would Pressure The DEA To Allow Patient Access To Psychedelics And Marijuana
Monday, July 25, 2022 - 4:06pm | 493On July 20, bipartisan lawmakers from both chambers of Congress sent companion bills clarifying that federal Right to Try (RTT) laws give terminally-ill patients access to Schedule I substances including marijuana and psychedelics. The legislation’s lead sponsors are Senators...
-
DEA Taken To Court Again For Access To Psilocybin For End-Of-Life Care
Monday, July 25, 2022 - 3:14pm | 538The Drug Enforcement Administration (DEA) has refused once more to a petition from a doctor to treat terminally-ill patients with psilocybin therapy, following federal and state “Right to Try” (RTT) laws. The agency is being takento court in a new case. A preceding litigation took...